Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Journal of Experimental & Clinical Cancer Research : CR|July 13, 2018
Simultaneous E-cadherin and PLEKHA7 expression negatively affects E-cadherin/EGFR mediated ovarian cancer cell growthKatia Rea, Francesca Roggiani, Loris De Cecco, et al.
Frontiers in Oncology|January 27, 2022
Complete Response to Nivolumab in Recurrent/Metastatic HPV-Positive Head and Neck Squamous Cell Carcinoma Patient After Progressive Multifocal Leukoencephalopathy: A Case ReportLaura Deborah Locati, Mara Serena Serafini, Andrea Carenzo, et al.
International Journal of Cancer|November 22, 2012
Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumorsGrazia Carbotti, Anna Maria Orengo, Delia Mezzanzanica, et al.
Biopreservation and Biobanking|July 13, 2016
Applicability of Under Vacuum Fresh Tissue Sealing and Cooling to Omics Analysis of Tumor TissuesSilvia Veneroni, Matteo Dugo, Maria Grazia Daidone, et al.
International Journal of Cancer|June 29, 2006
M-CAM expression as marker of poor prognosis in epithelial ovarian cancerDaniela Aldovini, Francesca Demichelis, Claudio Doglioni, et al.
NMR in Biomedicine|October 25, 2011
Characterisation of in vivo ovarian cancer models by quantitative 1H magnetic resonance spectroscopy and diffusion-weighted imagingRossella Canese, Maria Elena Pisanu, Delia Mezzanzanica, et al.
Oncotarget|August 14, 2014
Identification of a gene expression driven progression pathway in myxoid liposarcomaLoris De Cecco, Tiziana Negri, Silvia Brich, et al.
Molecular Oncology|June 20, 2017
β-Catenin in desmoid-type fibromatosis: deep insights into the role of T41A and S45F mutations on protein structure and gene expressionChiara Colombo, Antonino Belfiore, Nicholas Paielli, et al.
Oncotarget|September 4, 2015
Whole-transcriptome analysis links trastuzumab sensitivity of breast tumors to both HER2 dependence and immune cell infiltrationTiziana Triulzi, Loris De Cecco, Marco Sandri, et al.
Oncotarget|September 15, 2017
Phosphatidylcholine-specific phospholipase C inhibition reduces HER2-overexpression, cell proliferation and <i>in vivo</i> tumor growth in a highly tumorigenic ovarian cancer modelLuisa Paris, Franca Podo, Francesca Spadaro, et al.
Pageof 12